» Articles » PMID: 25714216

Therapeutic Options to Minimize Allogeneic Blood Transfusions and Their Adverse Effects in Cardiac Surgery: a Systematic Review

Overview
Date 2015 Feb 26
PMID 25714216
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Allogeneic blood is an exhaustible therapeutic resource. New evidence indicates that blood consumption is excessive and that donations have decreased, resulting in reduced blood supplies worldwide. Blood transfusions are associated with increased morbidity and mortality, as well as higher hospital costs. This makes it necessary to seek out new treatment options. Such options exist but are still virtually unknown and are rarely utilized.

Objective: To gather and describe in a systematic, objective, and practical way all clinical and surgical strategies as effective therapeutic options to minimize or avoid allogeneic blood transfusions and their adverse effects in surgical cardiac patients.

Methods: A bibliographic search was conducted using the MeSH term "Blood Transfusion" and the terms "Cardiac Surgery" and "Blood Management." Studies with titles not directly related to this research or that did not contain information related to it in their abstracts as well as older studies reporting on the same strategies were not included.

Results: Treating anemia and thrombocytopenia, suspending anticoagulants and antiplatelet agents, reducing routine phlebotomies, utilizing less traumatic surgical techniques with moderate hypothermia and hypotension, meticulous hemostasis, use of topical and systemic hemostatic agents, acute normovolemic hemodilution, cell salvage, anemia tolerance (supplementary oxygen and normothermia), as well as various other therapeutic options have proved to be effective strategies for reducing allogeneic blood transfusions.

Conclusion: There are a number of clinical and surgical strategies that can be used to optimize erythrocyte mass and coagulation status, minimize blood loss, and improve anemia tolerance. In order to decrease the consumption of blood components, diminish morbidity and mortality, and reduce hospital costs, these treatment strategies should be incorporated into medical practice worldwide.

Citing Articles

Patient Blood Management in Cardiovascular Surgery.

Cespedes I, Figueiredo M, Santos A, Hossne Junior N Braz J Cardiovasc Surg. 2024; e20240994(e20240994).

PMID: 39471260 PMC: 11500607. DOI: 10.21470/1678-9741-2024-0994.


Evaluation of Red Blood Cell Biochemical Markers and Coagulation Profiles Following Cell Salvage in Cardiac Surgery: A Systematic Review and Meta-Analysis.

Caceres-Matos R, Luque-Oliveros M, Pabon-Carrasco M J Clin Med. 2024; 13(20).

PMID: 39458023 PMC: 11508477. DOI: 10.3390/jcm13206073.


Patient Blood Management Program Implementation: Comprehensive Recommendations and Practical Strategies.

Cespedes I, Figueiredo M, Hossne Junior N, Capraro Suriano I, de Cassia Rodrigues R, Barros M Braz J Cardiovasc Surg. 2024; 39(5):e20240205.

PMID: 39094093 PMC: 11296688. DOI: 10.21470/1678-9741-2024-0205.


Successful Case of Double Valve Replacement Surgery Using Autologous Blood Transfusion: A Patient's Autonomy Preserved with Excellent Clinical Outcome.

Mello M, Pereira-Rufino L, Colares F, Panfilio C, Souza A, Cespedes I Am J Case Rep. 2024; 25:e943675.

PMID: 39046936 PMC: 11299883. DOI: 10.12659/AJCR.943675.


The effectiveness of cell salvage in extracorporeal circulation surgeries in relation to use of health resources after use: A systematic review and meta-analysis.

Pabon-Carrasco M, Caceres-Matos R, Martinez-Flores S, Luque-Oliveros M Heliyon. 2024; 10(9):e30459.

PMID: 38720744 PMC: 11077044. DOI: 10.1016/j.heliyon.2024.e30459.


References
1.
Demetriades D, Chan L, Bhasin P, Berne T, Ramicone E, Huicochea F . Relative bradycardia in patients with traumatic hypotension. J Trauma. 1998; 45(3):534-9. DOI: 10.1097/00005373-199809000-00020. View

2.
Milas B, Jobes D, Gorman R . Management of bleeding and coagulopathy after heart surgery. Semin Thorac Cardiovasc Surg. 2001; 12(4):326-36. DOI: 10.1053/stcs.2000.20511. View

3.
Tinmouth A, MacDougall L, Fergusson D, Amin M, Graham I, Hebert P . Reducing the amount of blood transfused: a systematic review of behavioral interventions to change physicians' transfusion practices. Arch Intern Med. 2005; 165(8):845-52. DOI: 10.1001/archinte.165.8.845. View

4.
Hajjar L, Vincent J, Galas F, Nakamura R, Silva C, Santos M . Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010; 304(14):1559-67. DOI: 10.1001/jama.2010.1446. View

5.
Drueke T . Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant. 2001; 16 Suppl 7:25-8. DOI: 10.1093/ndt/16.suppl_7.25. View